• TYK Medicines set a private placement of 63,222,744 new H Shares to Qilu’s wholly owned unit Anchor International.
• Deal priced at HK$ 7.3 per share for gross proceeds of HK$ 461.53 million, equivalent to about RMB 400 million.
• Price implies a 13.3% discount to the July 21 close of HK$ 8.42.
• Qilu stake set at 14.26% post-issue, subject to completion; shares locked up for six months from listing.
• Placement tied to a TY-9591 China licensing and commercialization collaboration with total potential payments up to RMB 2.36 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TYK Medicines Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260721-12251376), on July 21, 2026, and is solely responsible for the information contained therein.